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This perspective summarises the first and long overdue RACK1 meeting held at the University of Limerick, Ireland,
May 2013, in which RACK1’s role in the immune system, the heart and the brain were discussed and its
contribution to disease states such as cancer, cardiac hypertrophy and addiction were described. RACK1 is a
scaffolding protein and a member of the WD repeat family of proteins. These proteins have a unique architectural
assembly that facilitates protein anchoring and the stabilisation of protein activity. A large body of evidence is
accumulating which is helping to define the versatile role of RACK1 in assembling and dismantling complex
signaling pathways from the cell membrane to the nucleus in health and disease. In this commentary, we first
provide a historical perspective on RACK1. We also address many of the pertinent and topical questions about this
protein such as its role in transcription, epigenetics and translation, its cytoskeletal contribution and the merits of
targeting RACK1 in disease.Historical perspective
It has been 20 years since RACK1 was cloned as the first
identified binding protein for Protein Kinase C (PKC),
and the road the Mochly-Rosen group took toward its
discovery was not trivial. The role of scaffolding proteins
in the temporal and spatial regulation of signal transduc-
tion seems obvious today, however, this was not the case
in the late 1980s when Prof. Daria Mochly-Rosen devel-
oped the hypothesis that anchoring/scaffolding proteins
control the specificity of substrate phosphorylation and
function of Protein Kinase C (PKC) isozymes. An alpha
phage display library/overlay assay strategy was used to
identify binding proteins that interact with active PKC
isoforms. To this day Dr. Ron remembers when one
gene product was identified and was termed RACK1 for
Receptor for Activated C Kinase [1]. Using very primi-
tive bioinformatics programs, RACK1 was identified as a
WD-40 motif protein with high homology to the beta
subunit of G protein (G-beta) [1]. Over the years, many
excellent studies expanded the role of RACK1 as a true
scaffolding protein that interacts with a large, diverse
group of proteins and by doing so, contributes to the
regulation of various signaling cascades and biological
functions (for a recent review see [2]). Therefore, it is
not entirely surprising that the amino acid sequence of* Correspondence: Patrick.Kiely@ul.ie
6Department of Life Sciences, Materials and Surface Science Institute and
Stokes Institute, University of Limerick, Limerick, Ireland
Full list of author information is available at the end of the article
© 2013 Ron et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the orRACK1 is highly conserved throughout evolution, that
the protein is highly expressed in all mammalian cells,
and that a global deletion of the RACK1 gene is embry-
onically lethal [3]. Other unique characteristics of this
fascinating protein are its ability to translocate from one
cellular compartment to another, to form homo- and
heterodimers with itself and with G-beta as well as with
other scaffolding proteins such as 14-3-3zeta, and to
contribute to translation and transcription events [2,4].
Finally, as described below a new frontier in RACK1 re-
search is recently emerging as studies reveal that RACK1
interacts with several cytoskeletal proteins, thus suggesting
a role in cell trafficking and morphology.
RACK1 as a scaffolding protein
The conserved seven blade propeller structure of RACK1
facilitates the folding order into constituent propeller
blades. These propeller blades are intrinsic to RACK1’s
protein binding capacity and allow RACK1 to function
as a signaling hub [2]. Comments are often directed at
RACK1 biologists questioning the capacity of this protein
to bind to diverse signaling and structural proteins.
However, it is easy to forget that there is an estimated
100 million individual proteins involved in signal trans-
duction pathways within a cellular milieu [5]. Scaffolding
proteins, such as RACK1 organise proteins into linear
and branching signaling networks and several scaffolding
proteins can function within a particular signaling path-
way [6]. For example, there are at least 10 scaffolding. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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MAPK pathway in mammalian cells [7]. Collectively,
these scaffolding proteins are known to bind hundreds of
different proteins. In its capacity, RACK1 is no dif-
ferent from other well studied scaffolding proteins such
as Ras GTPase-activating-like protein (IQGAP1) and
Beta-arrestin in its ability to bind many diverse signal-
ing proteins [8-11]. Furthermore, when bound to scaf-
folding proteins, the local concentration of a signaling
protein is increased. For this reason, it is essential that
the scaffolds expression level is tightly controlled and
even a slight deviation from the optimum expression
level can have dramatic consequences for signaling net-
works and the cell.
RACK1: a scaffolding protein with a central role
in transcription, epigenetics & translation
RACK1 has a strong effect on transcription and transla-
tion by acting at critical points; principally the riboso-
mal small subunit and via nuclear translocation and
regulation of chromatin and transcriptional complexes
[2]. All available crystal structures of ribosomal 40S
subunits include an accessible RACK1 molecule that
can also bind to the translational initiation EIF3 complex
and other signaling proteins [12-16]. Thus, RACK1 has
potential to dock membrane-associated signaling com-
plexes with translationally competent ribosomes to con-
trol spatial translation [2]. This is consistent with its
scaffolding of Integrins with IGF-1R and Focal Adhesion
signaling complexes [17-20] in cancer cells where local
translation would facilitate migration. RACK1 may also
regulate cellular responses to metabolic stress during
translation. Its recruitment to RNA stress granules that
form at translationally stalled mRNAs [21] is thought
to prevent activation of stress kinase (p39, JNK) path-
ways and thereby allow cells to recover from stress ra-
ther than undergo apoptosis [22]. While transcription
factors can be translationally controlled by RACK1,
nuclear transcriptional complexes and chromatin may
also be modulated by its association. This was dem-
onstrated for the transcriptional response of the brain-
derived neurotrophic factor (BDNF) in neurons. RACK1
becomes translocated to the nucleus in association with
the scaffolding protein 14-33zeta in response to cAMP
signaling to promote chromatin remodelling that in-
cludes H4 histone acetylation resulting in BDNF tran-
scription [4,23]. This illustrates potential for RACK1 to
be selectively translocated to the nucleus in response to
cellular signals and suggests that RACK1 will be found
within other transcriptional complexes as a critical medi-
ator of dynamic cytoplasmic to nuclear signaling re-
sponses for environmental cues that control neuronal
plasticity, epithelial cells migration or differentiation, and
immune responses.RACK1 and cytoskeletal proteins: a new frontier
The cellular cytoskeleton, whose major components com-
prise of actin, microtubules and intermediate filaments,
maintains cellular integrity and regulates multiple cellu-
lar functions including migration [24,25]. Localization of
RACK1 at the cell membrane is consistent with its asso-
ciation with Beta-spectrin, a cytoskeletal protein that, as
a heterodimer, forms a meshwork lining the intracellular
side of the plasma membrane maintaining cytoskeletal
structure and membrane integrity. This RACK1-Beta
spectrin interaction facilitates PKCbeta localisation and
represents a focal point for pleckstrin homology (PH)
domain-containing substrates of this kinase [26]. RACK1
has also been shown to contribute to cell migration and
is a crucial component and regulator of focal adhesion
assembly/disassembly [17,27]. Focal adhesions are rich in
cytoskeletal linker proteins including talin and paxillin
which in turn are important regulators of the actin cyto-
skeleton. Through the regulation of Src kinase activity,
RACK1 modulates paxillin phosphorylation, a key step
in early adhesion formation during migration [28]. Earlier
studies in yeast demonstrated that a RACK1 homolog
Rkp1/Cpc2, regulates the integrity of the actin cytoskeleton
during cell wall synthesis while in human platelets, RACK1
mediates the interaction between PKCbeta and alphaII/
betaIII integrin, regulating actin cytoskeletal reorganisation
and platelet spreading on fibrinogen [29,30]. Interestingly,
in NIH 3 T3 cells, RACK1 was shown to inhibit Src-
mediated p190RhoGAP signaling and actin cytoskeleton
rearrangement [31]. Plectin is an intermediate filament
(IF)-associated linker protein that also functions to regu-
late actin dynamics and serves as a scaffold for signaling
proteins. RACK1-Plectin interactions are particularly im-
portant in recruiting and maintaining kinases at the IF
cytoskeleton, regulating keratin architecture, adhesion and
migration in epithelial cells [32,33]. The RACK1-Keratin
interaction is also important in regulation of PKCalpha
activity and stabilisation of desmosomes to control inter-
cellular adhesion [34]. Non-mechanical cellular functions
are also impacted by RACK1-Plectin mediated regulation
of keratins and include the modulation of G1/S transi-
tion and MAP kinase activity [31,32]. Given the import-
ance of phosphorylation and protein-protein interactions
in the regulation of the cytoskeleton, further roles for
RACK1 in this process are sure to emerge. In particular,
the role of RACK1 in microtubule (MT) polymerisation,
actin-MT interactions and regulation of cell polarity rep-
resent interesting candidates.
RACK1 as a potential therapeutic target
As the number of binding partners and validated cellular
functions for RACK1 has increased, so has its link with
an array of disease states [2]. In many RACK1-associated
pathological states, aberrant RACK1 signaling, which
Ron et al. Cell Communication and Signaling 2013, 11:53 Page 3 of 4
http://www.biosignaling.com/content/11/1/53underpins the condition, arises from either increased or
decreased expression of the scaffolding protein (reviewed
in [2]). Presumably, sub-optimal protein levels of RACK1
interferes with its compartmentalisation and, in turn,
hinder the formation of signaling complexes with cor-
rect stoichiometry at discrete intracellular locations.
Cell permeable peptides that act to disrupt the inter-
action of a RACK1 “pool”, which associates with a
single binding partner (PDE4D5), have been success-
ful in inhibiting the metastasis and direction sensing
of cancer cells without affecting the plethora of other
vital RACK1 functions [27,35], Thus, it is reasonable
to conclude that the therapeutic potential of RACK1
could be realised by small molecules that selectively
target RACK1 interacting proteins. Indeed, two re-
cent reports have showcased co-crystal structures of
a RACK1-like, 7-bladed beta-propeller protein (WDR5
in this case) with small molecules that have been de-
veloped to interrupt binding of a single client protein
[36,37]. These studies, along with the work of Orlicky et al.
[38] are amongst the first describing beta-propeller/small
molecule complexes. Interestingly, the report by Senisterra
et al. [36], shows that a new small molecule can occupy
the central channel on one face of the beta-propeller.
For many beta-propellers this is a protein binding site,
as is the case with the cyclin E phosphodegron bin-
ding to FBXW7, a component of E3ubiquitin ligase
[39,40]. This research provides important precedent
for the targeting of beta-propeller sites with small
molecules and opens the way for protein-protein in-
hibitors for RACK1 that could potentially reverse the
pathologies mentioned above.
Concluding comments
There are, of course, numerous remaining questions that
are of great interest. For example, how can one protein
play such an important role in many and diverse biological
functions? Is it possible that a number of RACK1 binding
partners share common binding sites on RACK1? Is
RACK1 function and/or expression levels regulated by
posttranslational modifications such as phosphorylation,
sumoylation and ubiquitination? Does RACK1 contribute
to a large number of disease states and can RACK1 be
used as a target for drug development? These are exciting
times for RACK1 biologists. As more and more research
areas converge on RACK1, we can expect answers to
these questions to unfold. RACK1 biology would benefit
greatly from detailed mechanistic mathematical model-
ling and quantitative experimentation to help us compre-
hend how RACK1 functions in systems biology, beyond
its role as a scaffolding protein. We look forward to the
next RACK1 conference, which we have no doubt will
bring more exciting new data on the role of our favorite
protein in cellular functions.Competing interests
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